The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

6 Jul 2020 07:00

RNS Number : 0478S
Sabien Technology Group PLC
06 July 2020
 

6 July 2020

Sabien Technology Group plc

("Sabien" or the "Company")

Trading Update

The Covid-19 pandemic has affected the entire global economy and Sabien has not escaped its impact. However, in spite of this unprecedented disruption, Sabien's revenues doubled in the second half of the financial year compared to the first half. This brings total sales (unaudited) for the year to approximately £460,000 (FY19: £1,379,000). The decrease in full year sales, while disappointing, is explained by last year's revenues including an exceptional order of £846,375 and by three months of lost sales due to the Covid lockdown in this period.

However, the Board believes that first half sales represent a "low watermark" after several years of diminishing performance by the previous Board and management team. Since the new management team has taken charge earlier this year, sales prospects are demonstrably strengthening, and consistent year-on-year growth is expected as the Company transitions into a more realisable go-to market strategy based on an enhanced product and service proposition.

In addition, the Board has sought to protect shareholder value in challenging market conditions by placing a focus on cash management. During the year cash in the bank has increased to £777,848 at 30 June 2020 (30 June 2019: £738,000; 30 June 2018: £9,000). This includes a Covid business interruption loan of £181,000 from NatWest Bank received on 25 June.

While Covid uncertainty has made it impossible to achieve a profitable performance this year, costs have been tightly controlled within the operating business as follows:

· Following, the announcement of major new strategic shareholder on 3 September 2019, the management team has been restructured with the departure of the Alan O'Brien, CEO, (announced 5/11/19) and David Bakst, Managing Director (announced (29/5/20). Until further notice these functions will filled by Executive Chairman, Richard Parris. These changes will contribute an annual saving on the operating company payroll of more than £200,000 from 1 June 2020.

· The Board placed 85% of the workforce on Covid-19 furlough from 31 March 2020. This has mitigated payroll expenses for 25% of the financial year and has helped to preserve jobs and expertise. During this period the Company was unable gain access to customer sites to undertake any installations but background sales and planning tasks to have been undertaken to the extent possible using non-furloughed staff.

The Company has recently started a development project to "cloud enable" its existing M2G user base (up to circa 10,500 units). This will enable upselling opportunities to existing customers and provide a source of new subscription revenue within the next period. For the first time in the Company's history this will enable recurring revenues to be generated from its large installed base. It is anticipated this will also reduce the time to secure new orders and support an international channel partner programme. Early revenues from this new Cloud service are expected before the end of 2020.

Operationally, Sabien is planning a strong start to the new financial period with a backlog of more than 300 M2G units to install and a confirmed order book of approximately £140,000. Commencing 16 June 2020, staff are being phased back from furlough leave to enable the Company to start to install backlogged units. The limiting factor is regaining access to customer sites which have been in lockdown since March. It is likely that full operations will restored within 3 months, with a new look business focused increasingly on indirect selling through channel partners in the UK and the US.

Richard Parris, Chairman, said: "The Sabien operating business is entering the new financial year in good shape to deliver year-on-year growth, relative to FY2020. This is a direct result of the Board's restructuring of the management and sales teams. During FY2021 and beyond we are expecting a sales bounce from (1) a post-Covid investment focus on green technology and (2) recessionary sentiments across the economy that will place a immediate customer emphasis on cost reduction programmes with short payback windows. I believe Sabien is now well placed to benefit from both of these macro trends and, in conjunction with our cost control measures, the Company is in a strong position for a return to profitability. The Board thanks Sabien staff for their support and forbearance during the difficult time of furlough and we look forward to welcoming you back over the coming weeks."

 

For further information:

Sabien Technology Group plc

Richard Parris, Chairman

SPARK Advisory Partners Limited (Nominated Adviser)

Neil Baldwin / Matt Davis

Peterhouse Capital Limited (Broker)

Duncan Vasey/ Lucy Williams 

+44 20 7993 3700

 

+44 203 368 3550 

 

+44 207 469 0930

A copy of this announcement will be available from the Company's website at www.sabien-tech.co.uk

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKNBQABKDNOK
Date   Source Headline
26th Mar 20137:00 amRNSFireye Distributorship Agreement
12th Feb 20139:29 amRNSHolding(s) in Company
12th Feb 20137:00 amRNSHalf Yearly Report
6th Feb 20133:44 pmRNSHolding(s) in Company
6th Feb 20133:11 pmRNSChange of ACD for OEIC holding
31st Jan 201310:11 amRNSNotice of Results
22nd Nov 20127:00 amRNSAGM Statement
30th Oct 201210:44 amRNSGrant of share options
29th Oct 201210:19 amRNSDispatch of Annual Financial Report
17th Oct 20127:00 amRNSAppointment of Mrs Miriam Maes as a Director
1st Oct 20127:00 amRNSPreliminary Statement of Final Results
30th Aug 20122:30 pmRNSRetirement of Chairman
10th Jul 20127:00 amRNSPost Close Trading Statement
7th Mar 20127:00 amRNSRe Contract
7th Feb 20127:00 amRNSHalf Yearly Report
1st Feb 20127:00 amRNSRe-organisation of Nominated Adviser and Broker
12th Jan 201212:20 pmRNSDirector Declaration
12th Jan 20129:27 amRNSCapital Reorganisation
9th Jan 20127:00 amRNSNotice of Results
5th Jan 20127:00 amRNSChange of Adviser
19th Dec 201110:54 amRNSDirector Declaration
29th Nov 201110:19 amRNSHolding(s) in Company
24th Nov 20117:00 amRNSResult of AGM
21st Nov 201110:26 amRNSHolding(s) in Company
17th Nov 201111:23 amRNSHolding(s) in Company
4th Nov 20111:50 pmRNSHolding(s) in Company
1st Nov 20117:00 amRNSAnnual Report and Accounts
7th Oct 20117:00 amRNSNew Contract Win
3rd Oct 20117:00 amRNSFinal Results
12th Sep 20117:00 amRNSNew Contract Win
25th Aug 20117:00 amRNSNew Contract Win
11th Jul 20117:00 amRNSPost Year End Trading Update
29th Jun 20111:12 pmRNSM2G sale to US Distributor
2nd Jun 201112:15 pmRNSNotice of Results
8th Apr 201111:28 amRNSM2G sale to US Distributor
2nd Mar 201111:44 amRNSHolding(s) in Company
1st Mar 201111:08 amRNSHolding(s) in Company
7th Feb 20117:00 amRNSHalf Yearly Report
5th Jan 20117:00 amRNSNotice of Results and Trading Update
26th Nov 20107:00 amRNSDirector/PDMR Shareholding
25th Nov 20107:00 amRNSResult of AGM
17th Nov 20107:00 amRNSAward of Contract
12th Nov 20104:12 pmRNSAnnual Financial Report
29th Oct 20107:00 amRNSPreliminary Results
18th Oct 20107:00 amRNSNotice of Results
15th Oct 20107:00 amRNSDirectorate Change
20th Sep 20107:00 amRNSAward of Contract
6th Aug 20107:00 amRNSAward of Contract
5th Jul 20107:00 amRNSAward of Contract
24th Jun 20107:00 amRNSAward of Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.